RxDoctor Payments Data

Michael Giudici, MD

Clinical Cardiac Electrophysiology · Mason City, IANPI 1336128354

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Novartis at 33.6% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IA, where the typical reported total is $15,103.

$1,116in general payments, 2019–2025

Across 45 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$375
  • Boston Scientific$261
  • Boehringer Ingelheim$89
  • Impulse Dynamics (USA) Inc.$76
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$73
  • AstraZeneca$63
  • plus $179 from 8 others
$64,560in research payments, 2019–2025

Across 26 payments — averaging $2483.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$60K
  • Boehringer Ingelheim$5K

What the payments were for

  • Food & beverage$1,05494%
  • Education$626%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,116 in reported general payments places this provider in the 15th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

See all clinical cardiac electrophysiology providers in Iowa

Medicare billing

Part B allowed, 2024
$53,080
Medicare patients
1,363
Services billed
2,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$53,230
Metoprolol Succinate59$1,213
Flecainide Acetate22$961
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$517
Propafenone Hcl13$505
Atorvastatin Calcium23$292
Lisinopril18$219
Amiodarone Hcl12$157
Losartan Potassium17$89
Furosemide18$79
Spironolactone21$64

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$53,23064 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

Other clinical cardiac electrophysiology in Mason City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →